Art is Her Best Friend

Yvonne is living her dream. She is an artist, dedicated to raising awareness and funds for vision research.

Become a Community Fundraiser

Community events are a fun way for you to join the fight against blindness and fund sight saving research. Host a fundraiser in your community today!

Out-pacing vision loss

Cycle for Sight founder and co-chair, Michael Ovens, will cycle any distance or run any length to help support sight-saving research.

Meet Molly Burke, FFB Youth Ambassador

Youth Ambassador

Molly Burke is a youth ambassador for the Foundation Fighting Blindness, educating the public about living with blindness while delivering a message of hope to those living with vision impairment.

Meet Norma Bastidas, mom on a mission

Mom on a Mission

Norma is the second person in history to run 7 of the planet's most unforgiving environments on 7 continents in 1 year in support of vision research. Read her about incredible journey.

Meet Dale Turner, proof that research does work

Miracles do happen

Dale Turner is the first Canadian to receive an experimental treatment and have some sight restored by gene therapy. Dale is proof that investing in research works.

Research News

The Foundation Fighting Blindness is committed to funding sight-saving research across Canada and to keeping Canadians living with vision loss informed about the latest developments in vision research. News items and resources about emerging research are listed here. You can also see past issues of our monthly Vision Research e-News here!

Our Research News items are reviewed by Dr. Bill Stell, Expert Scientific Advisor for the Foundation Fighting Blindness. Dr. Stell is a Professor of Cell Biology and Anatomy; Surgery;  Ophthalmology; and Neurosciences at the University of Calgary.

June 17, 2014 - Eight New Sight-Saving Research Projects
With your support, the Foundation Fighting Blindness is funding new research projects to better understand and treat age-related macular degeneration, retinitis pigmentosa, Leber congenital amaurosis and other blinding retinal diseases.

May 27, 2014 - Update on the RPE65 Gene Therapy Trials
A phase III trial for this type of Leber congenital amaurosis is now underway. 

Association for Research in Vision and Ophthalmology
Conference Coverage 2014

The annual ARVO meeting is the world's largest conference for vision research. It is being held this year in Orlando, Florida. We'll provide updates throughout the meeting.

May 8, 2014 - Potential Therapy to Slow Retinal Vision Loss
Promising signs of advances towards a sight protecting therapy for retinitis pigmentosa

 

May 7, 2014 - Valproic Acid as a Treatment for Retinitis Pigmentosa
Early trials show some visual improvements, but the treatmetn may only be appropriate for some types of RP.

May 6, 2014 - Genetic Testing and Retinitis Pigmentosa
Dr. Robert Koenekoop and his colleagues present information about a new screening panel for retinitis pigmentosa

May 6, 2014 - The Long-Term Treatment of Wet AMD
A closer look at the outcomes for people receiving wet AMD injections over many years

May 4, 2014 - One Year Results of the Choroideremia Gene Therapy Trial Presented
British scientists present data from this ongoing trial

April 15, 2014 - Trial of Treatment to Slow Retinitis Pigmentosa Vision Loss Begins in Italy
The eye drop uses a nerve growth factor to protect photoreceptors.

March 31, 2014 - Geneticist's sight-saving contributions recognized
Dr. Jane Green received the Order of Newfoundland and Labrador

March 25, 2014 - A Link between Exercise and Vision Health
American scientists make the first report of simple exercise having a direct effect on retinal health and vision.

Feb 21, 2014 - New Compound May be the Basis of a Promising Drug to Reverse Retinal Blindness
California researchers invent a new "photoswitch," which may give light-sensing capacity to retinal nerve cells potentially restoring vision to people with advanced retinal degenerative diseases.

Feb 5, 2014 - Testing the Safety of Induced Stem Cell Therapies
Cells derived from induced pluipotent stem cells will soon be used in a clinical trial for dry age-related macular degeneration and may be used for other conditions as well. How are scientists assessing the risks?  

Jan 16, 2014 - First gene therapy results for choroideremia suggest cautious optimism
Of first six patients treated in the British gene therapy trial for choroideremia, the two most visually impaired experience the most strikingly positive results.

Jan 8, 2014 - Allergies may protect against age-related macular degeneration
In a new, and unexpected research finding people with a history of allergies may be less likely to have AMD.

 

Donations to the Foundation Fighting Blindness support research teams across Canada. See our annual wrap-up of Ten 2013 Research Discoveries.

2013 Research News Archive / 2012 Research News Archive

You can help – support us today!

Privacy Policy | Accessibility Policy